Fierce Biotech

Inflammation biotech Evommune prices IPO after MapLight’s $250M debut

Inflammation biotech Evommune plans to take the leap into public waters with an expected initial public offering price of $15 ...

Princes London IPO meets lukewarm reception from investors

Princes, a manufacturer of tinned fish, chopped tomatoes and cooking oil, priced its shares at 475p, at the bottom of the ...

Renaissance Capital Opens New Circle Internet Group (NASDAQ: CRCL) Position: Is the New IPO a Buy?

According to a filing with the Securities and Exchange Commission dated October 20, 2025, Renaissance Capital reported a new ...

Navan IPO tumbles 20% after historic debut under SEC shutdown workaround

Navan finished its first day trading at an approximate valuation of $4.7 billion, which is about half of its last private ...

Navan Debut Is the Latest ‘Down Round IPO’

A handful of companies that have gone public have failed to match the frothy valuations set in their venture-backed rounds.

Orkla India IPO Day 3 LIVE: Last day to apply for MTR's parent firm — Check latest GMP

Investors have the last chance to apply for the Orkla India IPO today. The company’s ₹1,667 crore IPO is being sold in the ...

Orkla India vs Studds vs Lenskart IPO: Check subscription & latest GMPs of 3 issues

Three mainboard IPOs- Orkla India, Studds Accessories and Lenskart Solutions- are open for investors for primary market ...

Navan slips in Nasdaq debut as US government shutdown tests IPO market

Navan's shares started trading 12% below their initial public offering price on Thursday, as the travel technology company ...